Genetic Variation and Neuroplasticity: Role in Rehabilitation after Stroke

Journal of Neurologic Physical Therapy

Volumn 41, Issue , 2017, Pages S17-S23

  Stewart, Jill Campbell ^a   Cramer, Steven C ^b  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

motor learning; polymorphism; predictive models; recovery

Indexed keywords

CEREBROVASCULAR ACCIDENT; CONVALESCENCE; GENETIC VARIATION; GENETICS; HUMAN; NERVE CELL PLASTICITY; PATHOPHYSIOLOGY; PYRAMIDAL TRACT; STROKE REHABILITATION;

GENETIC VARIATION; HUMANS; NEURONAL PLASTICITY; PYRAMIDAL TRACTS; RECOVERY OF FUNCTION; STROKE; STROKE REHABILITATION;

EID: 85021795069     PISSN: 15570576     EISSN: 15570584     Source Type: Journal    
DOI: 10.1097/NPT.0000000000000180     Document Type: Conference Paper

References (97)

1. Cheeran BJ, Ritter C, Rothwell JC, Siebner HR,. Mapping genetic influences on the corticospinal motor system in humans. Neuroscience. 2009; 164 (1): 156-163.
2. Pearson-Fuhrhop KM, Kleim JA, Cramer SC,. Brain plasticity and genetic factors. Top Stroke Rehabil. 2009; 16 (4): 282-299.
3. Musunuru K, Hickey KT, Al-Khatib SM, Basic concepts and potential applications of genetics and genomics for cardiovascular and stroke clinicians: A scientific statement from the American Heart Association. Circ Cardiovasc Genet. 2015; 8 (1): 216-242.
4. Roth SM,. Genetics Primer for Exercise Science and Health. Champaign, IL: Human Kinetics; 2007.
5. Cramer SC, Sur M, Dobkin BH, Harnessing neuroplasticity for clinical applications. Brain. 2011; 134 (pt 6): 1591-1609.
6. Winstein CJ, Wolf SL,. Task-oriented training to promote upper extremity recovery. In: Stein J, Harvey RL, Macko R, Winstein C, Zorowitz R, eds. Stroke Recovery & Rehabilitation. New York, NY: Demos Medical; 2008: 267-290.
7. Mang CS, Campbell KL, Ross CJ, Boyd LA,. Promoting neuroplasticity for motor rehabilitation after stroke: considering the effects of aerobic exercise and genetic variation on brain-derived neurotrophic factor. Phys Ther. 2013; 93 (12): 1707-1716.
8. Liew SL, Santarnecchi E, Buch ER, Cohen LG,. Non-invasive brain stimulation in neurorehabilitation: local and distant effects for motor recovery. Front Hum Neurosci. 2014; 8: 378.
9. Cotman CW, Berchtold NC,. Exercise: A behavioral intervention to enhance brain health and plasticity. Trends Neurosci. 2002; 25 (6): 295-301.
10. Kleim JA, Jones TA, Schallert T,. Motor enrichment and the induction of plasticity before or after brain injury. Neurochem Res. 2003; 28 (11): 1757-1769.
11. Casey BJ, Glatt CE, Tottenham N, Brain-derived neurotrophic factor as a model system for examining gene by environment interactions across development. Neuroscience. 2009; 164 (1): 108-120.
12. Balkowiec A, Katz DM,. Cellular mechanisms regulating activity-dependent release of native brain-derived neurotrophic factor from hippocampal neurons. J Neurosci. 2002; 22 (23): 10399-10407.
13. Ploughman M, Windle V, MacLellan CL, White N, Dore JJ, Corbett D,. Brain-derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats. Stroke. 2009; 40 (4): 1490-1495.
14. Gomez-Pinilla F, Ying Z, Roy RR, Molteni R, Edgerton VR,. Voluntary exercise induces a BDNF-mediated mechanism that promotes neuroplasticity. J Neurophysiol. 2002; 88 (5): 2187-2195.
15. MacLellan CL, Keough MB, Granter-Button S, Chernenko GA, Butt S, Corbett D,. A critical threshold of rehabilitation involving brain-derived neurotrophic factor is required for poststroke recovery. Neurorehabil Neural Repair. 2011; 25 (8): 740-748.
16. 66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003; 112 (2): 257-269.
17. 66met) polymorphism frequencies: The possibility to explain ethnic mental traits. Am J Med Genet B Neuropsychiatr Genet. 2004; 126b (1): 122-123.
18. 66met polymorphism is associated with modified experience-dependent plasticity in human motor cortex. Nat Neurosci. 2006; 9 (6): 735-737.
19. 66met polymorphism influences motor system function in the human brain. Cereb Cortex. 2010; 20 (5): 1254-1262.
20. 66met polymorphism is related to motor system function after stroke. Phys Ther. 2016; 96 (4): 533-539.
21. McHughen SA, Cramer SC,. The BDNF val(66)met polymorphism is not related to motor function or short-Term cortical plasticity in elderly subjects. Brain Res. 2013; 1495: 1-10.
22. Cheeran B, Talelli P, Mori F, A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. J Physiol. 2008; 586 (23): 5717-5725.
23. Hwang JM, Kim YH, Yoon KJ, Uhm KE, Chang WH,. Different responses to facilitatory rTMS according to BDNF genotype. Clin Neurophysiol. 2015; 126 (7): 1348-1353.
24. 66met polymorphism. PLoS One. 2013; 8 (2): e57690.
25. Antal A, Chaieb L, Moliadze V, Brain-derived neurotrophic factor (BDNF) gene polymorphisms shape cortical plasticity in humans. Brain Stimul. 2010; 3 (4): 230-237.
26. Cirillo J, Hughes J, Ridding M, Thomas PQ, Semmler JG,. Differential modulation of motor cortex excitability in BDNF Met allele carriers following experimentally induced and use-dependent plasticity. Eur J Neurosci. 2012; 36 (5): 2640-2649.
27. Fritsch B, Reis J, Martinowich K, Direct current stimulation promotes BDNF-dependent synaptic plasticity: potential implications for motor learning. Neuron. 2010; 66 (2): 198-204.
28. 66met polymorphism on visuomotor adaptation. Exp Brain Res. 2012; 223 (1): 43-50.
29. Li Voti P, Conte A, Suppa A, Correlation between cortical plasticity, motor learning and BDNF genotype in healthy subjects. Exp Brain Res. 2011; 212 (1): 91-99.
30. 66met polymorphism in the brain-derived neurotrophic factor (BDNF) gene. Neurosci Lett. 2011; 487 (3): 264-267.
31. Beninger RJ,. The role of dopamine in locomotor activity and learning. Brain Res. 1983; 287 (2): 173-196.
32. Nieoullon A,. Dopamine and the regulation of cognition and attention. Prog Neurobiol. 2002; 67 (1): 53-83.
33. Egerton A, Mehta MA, Montgomery AJ, The dopaminergic basis of human behaviors: A review of molecular imaging studies. Neurosci Biobehav Rev. 2009; 33 (7): 1109-1132.
34. Opmeer EM, Kortekaas R, Aleman A,. Depression and the role of genes involved in dopamine metabolism and signalling. Prog Neurobiol. 2010; 92 (2): 112-133.
35. Blum K, Chen AL, Giordano J, The addictive brain: All roads lead to dopamine. J Psychoactive Drugs. 2012; 44 (2): 134-143.
36. Salamone JD, Correa M,. The mysterious motivational functions of mesolimbic dopamine. Neuron. 2012; 76 (3): 470-485.
37. Tritsch NX, Sabatini BL,. Dopaminergic modulation of synaptic transmission in cortex and striatum. Neuron. 2012; 76 (1): 33-50.
38. Hosp JA, Luft AR,. Dopaminergic meso-cortical projections to M1: role in motor learning and motor cortex plasticity. Front Neurol. 2013; 4: 145.
39. Calabresi P, Picconi B, Tozzi A, Di Filippo M,. Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci. 2007; 30 (5): 211-219.
40. Molina-Luna K, Pekanovic A, Rohrich S, Dopamine in motor cortex is necessary for skill learning and synaptic plasticity. PLoS One. 2009; 4 (9): e7082.
41. Hosp JA, Pekanovic A, Rioult-Pedotti MS, Luft AR,. Dopaminergic projections from midbrain to primary motor cortex mediate motor skill learning. J Neurosci. 2011; 31 (7): 2481-2487.
42. Pearson-Fuhrhop KM, Minton B, Acevedo D, Shahbaba B, Cramer SC,. Genetic variation in the human brain dopamine system influences motor learning and its modulation by l-Dopa. PLoS One. 2013; 8 (4): e61197.
43. Egan MF, Goldberg TE, Kolachana BS, Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A. 2001; 98 (12): 6917-6922.
44. Gilbert DL, Wang Z, Sallee FR, Dopamine transporter genotype influences the physiological response to medication in ADHD. Brain. 2006; 129 (pt 8): 2038-2046.
45. Thompson J, Thomas N, Singleton A, D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics. 1997; 7 (6): 479-484.
46. Zheng SL, Sun J, Wiklund F, Cumulative association of five genetic variants with prostate cancer. N Engl J Med. 2008; 358 (9): 910-919.
47. Hamrefors V, Orho-Melander M, Krauss RM, A gene score of nine LDL and HDL regulating genes is associated with fluvastatin-induced cholesterol changes in women. J Lipid Res. 2010; 51 (3): 625-634.
48. Sanchez-Navarro I, Gamez-Pozo A, Pinto A, An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer. BMC Cancer. 2010; 10: 336.
49. Lyssenko V, Jonsson A, Almgren P, Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med. 2008; 359 (21): 2220-2232.
50. Meigs JB, Shrader P, Sullivan LM, Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med. 2008; 359 (21): 2208-2219.
51. Pearson-Fuhrhop KM, Dunn EC, Mortero S, Dopamine genetic risk score predicts depressive symptoms in healthy adults and adults with depression. PLoS One. 2014; 9 (5): e93772.
52. MacDonald HJ, Stinear CM, Ren A, Dopamine gene profiling to predict impulse control and effects of dopamine agonist ropinirole. J Cogn Neurosci. 2016; 28 (7): 909-919.
53. Kalia LV, Lang AE,. Parkinson's disease. Lancet. 2015; 386 (9996): 896-912.
54. Fallon SJ, Smulders K, Esselink RA, van de Warrenburg BP, Bloem BR, Cools R,. Differential optimal dopamine levels for set-shifting and working memory in Parkinson's disease. Neuropsychologia. 2015; 77: 42-51.
55. 158met polymorphism. Mov Disord. 2004; 19 (8): 885-891.
56. 158met and cognitive function in Parkinson's disease. Mov Disord. 2010; 25 (15): 2550-2554.
57. Habak C, Noreau A, Nagano-Saito A, Dopamine transporter SLC6A3 genotype affects cortico-striatal activity of set-shifts in Parkinson's disease. Brain. 2014; 137 (pt 11): 3025-3035.
58. 158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease. J Neurosci. 2007; 27 (18): 4832-4838.
59. Williams-Gray CH, Hampshire A, Barker RA, Owen AM,. Attentional control in Parkinson's disease is dependent on COMT val 158 met genotype. Brain. 2008; 131 (pt 2): 397-408.
60. Masellis M, Collinson S, Freeman N, Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: A pharmacogenetic study. Brain. 2016; 139 (pt 7): 2050-2062.
61. Moreau C, Meguig S, Corvol JC, Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease. Brain. 2015; 138 (pt 5): 1271-1283.
62. Kwak Y, Bohnen NI, Muller ML, Dayalu P, Burke DT, Seidler RD,. Task-dependent interactions between dopamine D2 receptor polymorphisms and L-DOPA in patients with Parkinson's disease. Behav Brain Res. 2013; 245: 128-136.
63. Arendt T, Schindler C, Bruckner MK, Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. J Neurosci. 1997; 17 (2): 516-529.
64. White F, Nicoll JA, Roses AD, Horsburgh K,. Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion. Neurobiol Dis. 2001; 8 (4): 611-625.
65. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE,. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 1994; 264 (5160): 850-852.
66. Schiefermeier M, Kollegger H, Madl C, Apolipoprotein E polymorphism: survival and neurological outcome after cardiopulmonary resuscitation. Stroke. 2000; 31 (9): 2068-2073.
67. Liu Y, Yu JT, Wang HF, APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-Analysis. J Neurol Neurosurg Psychiatry. 2015; 86 (2): 127-134.
68. Poirier J, Minnich A, Davignon J,. Apolipoprotein E, synaptic plasticity and Alzheimer's disease. Ann Med. 1995; 27 (6): 663-670.
69. Lawrence DW, Comper P, Hutchison MG, Sharma B,. The role of apolipoprotein E episilon (epsilon)-4 allele on outcome following traumatic brain injury: A systematic review. Brain Inj. 2015; 29 (9): 1018-1031.
70. McCarron MO, Weir CJ, Muir KW, Effect of apolipoprotein E genotype on in-hospital mortality following intracerebral haemorrhage. Acta Neurol Scand. 2003; 107 (2): 106-109.
71. Gallek MJ, Conley YP, Sherwood PR, Horowitz MB, Kassam A, Alexander SA,. APOE genotype and functional outcome following aneurysmal subarachnoid hemorrhage. Biol Res Nurs. 2009; 10 (3): 205-212.
72. Cramer SC, Procaccio V,. Correlation between genetic polymorphisms and stroke recovery: Analysis of the GAIN Americas and GAIN International Studies. Eur J Neurol. 2012; 19 (5): 718-724.
73. Skriver K, Roig M, Lundbye-Jensen J, Acute exercise improves motor memory: exploring potential biomarkers. Neurobiol Learn Mem. 2014; 116: 46-58.
74. Szuhany KL, Bugatti M, Otto MW,. A meta-Analytic review of the effects of exercise on brain-derived neurotrophic factor. J Psychiatr Res. 2015; 60: 56-64.
75. Chang WH, Bang OY, Shin YI, Lee A, Pascual-Leone A, Kim YH,. BDNF polymorphism and differential rTMS effects on motor recovery of stroke patients. Brain Stimul. 2014; 7 (4): 553-558.
76. Uhm KE, Kim YH, Yoon KJ, Hwang JM, Chang WH,. BDNF genotype influence the efficacy of rTMS in stroke patients. Neurosci Lett. 2015; 594: 117-121.
77. Ridding MC, Ziemann U,. Determinants of the induction of cortical plasticity by non-invasive brain stimulation in healthy subjects. J Physiol. 2010; 588 (pt 13): 2291-2304.
78. Helm EE, Tyrell CM, Pohlig RT, Brady LD, Reisman DS,. The presence of a single-nucleotide polymorphism in the BDNF gene affects the rate of locomotor adaptation after stroke. Exp Brain Res. 2016; 234 (2): 341-351.
79. Kim JM, Stewart R, Park MS, Associations of BDNF genotype and promoter methylation with acute and long-Term stroke outcomes in an East Asian cohort. PLoS One. 2012; 7 (12): e51280.
80. Mirowska-Guzel D, Gromadzka G, Mendel T, Impact of BDNF-196 G>A and BDNF-270 C>T polymorphisms on stroke rehabilitation outcome: sex and age differences. Top Stroke Rehabil. 2014; 21 (suppl 1): S33-S41.
81. Siironen J, Juvela S, Kanarek K, Vilkki J, Hernesniemi J, Lappalainen J,. The Met allele of the BDNF Val66Met polymorphism predicts poor outcome among survivors of aneurysmal subarachnoid hemorrhage. Stroke. 2007; 38 (10): 2858-2860.
82. Zhao J, Wu H, Zheng L, Weng Y, Mo Y,. Brain-derived neurotrophic factor G196A polymorphism predicts 90-day outcome of ischemic stroke in Chinese: A novel finding. Brain Res. 2013; 1537: 312-318.
83. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333 (24): 1581-1587.
84. Stewart JC, Cramer SC,. Patient-reported measures provide unique insights into motor function after stroke. Stroke. 2013; 44 (4): 1111-1116.
85. Cramer SC, Koroshetz WJ, Finklestein SP,. The case for modality-specific outcome measures in clinical trials of stroke recovery-promoting agents. Stroke. 2007; 38 (4): 1393-1395.
86. Burke Quinlan E, Dodakian L, See J, Neural function, injury, and stroke subtype predict treatment gains after stroke. Ann Neurol. 2015; 77 (1): 132-145.
87. Byblow WD, Stinear CM, Barber PA, Petoe MA, Ackerley SJ,. Proportional recovery after stroke depends on corticomotor integrity. Ann Neurol. 2015; 78 (6): 848-859.
88. Shiner CT, Pierce KD, Thompson-Butel AG, Trinh T, Schofield PR, McNulty PA,. BDNF genotype interacts with motor function to influence rehabilitation responsiveness poststroke. Front Neurol. 2016; 7: 69.
89. Riley JD, Le V, Der-Yeghiaian L, Anatomy of stroke injury predicts gains from therapy. Stroke. 2011; 42 (2): 421-426.
90. Bonilha L, Rorden C, Fridriksson J,. Assessing the clinical effect of residual cortical disconnection after ischemic strokes. Stroke. 2014; 45 (4): 988-993.
91. Adams H, Bendixen B, Kappelle L, Classification of subtype of acute ischemic stroke. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993; 24 (1): 35-41.
92. Thickbroom GW, Cortes M, Rykman A, Stroke subtype and motor impairment influence contralesional excitability. Neurology. 2015; 85 (6): 517-520.
93. Witte AV, Kurten J, Jansen S, Interaction of BDNF and COMT polymorphisms on paired-Associative stimulation-induced cortical plasticity. J Neurosci. 2012; 32 (13): 4553-4561.
94. Stinear CM, Barber PA, Petoe M, Anwar S, Byblow WD,. The PREP algorithm predicts potential for upper limb recovery after stroke. Brain. 2012; 135 (pt 8): 2527-2535.
95. Stinear CM, Ward NS,. How useful is imaging in predicting outcomes in stroke rehabilitation? Int J Stroke. 2013; 8 (1): 33-37.
96. Coupar F, Pollock A, Rowe P, Weir C, Langhorne P,. Predictors of upper limb recovery after stroke: A systematic review and meta-Analysis. Clin Rehabil. 2012; 26 (4): 291-313.
97. Falcone GJ, Malik R, Dichgans M, Rosand J,. Current concepts and clinical applications of stroke genetics. Lancet Neurol. 2014; 13 (4): 405-418.